This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Investors Should Hold Corebridge (CRBG) Stock Now
by Zacks Equity Research
Improving premiums, fee and investment income and streamlining initiatives bode well for Corebridge (CRBG).
MetLife (MET) Arm MIM Secures $1.2B for 2nd Private Equity Fund
by Zacks Equity Research
MetLife (MET) Arm, MIM, plans to utilize $250 million on new private equity opportunities.
Wall Street Analysts See a 35.78% Upside in EverQuote (EVER): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 35.8% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
EverQuote (EVER) Rallies 220% in a Year: What's Driving It?
by Zacks Equity Research
EverQuote (EVER) rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Here's Why Radian Group (RDN) Stock is an Attractive Pick Now
by Zacks Equity Research
Radian Group (RDN) stands to gain from strong persistency rates, improved new insurance written, a strong capital position, favorable growth estimates and effective capital deployment.
Unum (UNM) Shares Gain 12% YTD: Will the Upside Continue?
by Zacks Equity Research
Favorable sales trends and risk experience, strong persistency, an improving rate environment and a solid capital position poise Unum (UNM) well.
Here's Why EverQuote (EVER) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Hold Strategy is Apt for MGIC Investment (MTG)
by Zacks Equity Research
MGIC Investment (MTG) is well-poised to gain from solid insurance in force, a decline in loss and claims payments, better housing market fundamentals and prudent capital deployment.
Reasons Why Investors Should Retain Assurant (AIZ) Stock Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses, solid capital management and effective capital deployment.
Reinsurance Group (RGA) Up 28.4% YTD: More Room for Growth?
by Zacks Equity Research
Reinsurance Group (RGA) gains from improved pricing, a solid in-force business, an improving interest rate environment, favorable growth estimates and prudent capital deployment.
Here's Why Hold Strategy is Apt for Voya Financial (VOYA)
by Zacks Equity Research
Voya Financial (VOYA) is well-poised to gain from favorable retention, positive impacts of the Benefitfocus buyout, higher investment income and surplus income.
Here's Why Hold Strategy is Apt for Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) stands to gain from an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Here's Why Hold Strategy is Apt for CME Group (CME) Stock
by Zacks Equity Research
CME Group (CME) stands to benefit from its global presence, compelling product portfolio and focus on over-the-counter clearing services and optimistic growth projections.
Down -20.94% in 4 Weeks, Here's Why EverQuote (EVER) Looks Ripe for a Turnaround
by Zacks Equity Research
EverQuote (EVER) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Here's Why Hold Strategy is Apt for Prudential Financial (PRU)
by Zacks Equity Research
Prudential Financial (PRU) is well-poised to gain from the growing pension risk transfer market, higher emerging markets earnings, strategic acquisitions and effective capital deployment.
Coinbase Global (COIN) Up 394.8% in a Year: Will the Rally Last?
by Zacks Equity Research
Coinbase Global (COIN) is poised to gain from higher average fees, growing average crypto asset prices, investments in technology, improved Crypto trading and expansion of international operations.
Should You Add Old Republic (ORI) Stock for Better Returns?
by Zacks Equity Research
Old Republic (ORI) stands to gain from higher premiums in commercial auto, financial indemnity and property coverages, favorable growth estimates and a solid balance sheet.
Why EverQuote (EVER) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from higher net added customers, growth in overall average policy value, expanded geographic footprint and a solid capital position.
EverQuote (EVER) Surges 89.6% YTD: Will the Rally Last?
by Zacks Equity Research
EverQuote (EVER) stock rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Why Is EverQuote (EVER) Down 12% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street Analysts Think EverQuote (EVER) Could Surge 34.55%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 34.6% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Here's Why You Should Add Radian Group (RDN) in Your Portfolio
by Zacks Equity Research
Radian Group (RDN) stands to gain from strong persistency rates, improved new insurance written, a strong capital position, favorable growth estimates and effective capital deployment.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.